• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Glaukos Corp (NY: GKOS )

    143.04 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EST, Nov 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Glaukos Corp

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    Glaukos Reports 30% Boost In Glaucoma Sales, Improved Margins In Q3, Analyst Highlights Certain Headwinds
    Glaukos Corporation's Q3 revenue grew 24% to $96.7 million, beating estimates, with an EPS loss of $(0.28). 2024 sales guidance raised despite anticipated headwinds. 
    Via Benzinga
    Glaukos Announces Third Quarter 2024 Financial Results
    From Glaukos Corporation
    Via Business Wire
    How Is The Market Feeling About Glaukos?
    Via Benzinga
    Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety
    From Glaukos Corporation
    Via Business Wire
    A Closer Look at 7 Analyst Recommendations For Glaukos
    Via Benzinga
    Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
    From Glaukos Corporation
    Via Business Wire
    Navigating 11 Analyst Ratings For Glaukos
    Via Benzinga
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    Glaukos Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)
    Via Benzinga
    10 Analysts Have This To Say About Glaukos
    Via Benzinga
    Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
    Via Benzinga
    Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q2 2024
    GKOS stock results show that Glaukos missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Glaukos Announces Second Quarter 2024 Financial Results
    From Glaukos Corporation
    Via Business Wire
    7 Leading MedTech Stocks for Next-Gen Health Solutions
    With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar. 
    Via InvestorPlace
    This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
    Via Benzinga
    Analyst Ratings For Glaukos
    Via Benzinga
    Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
    Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%. 
    Via Benzinga
    Topics Earnings
    Exposures Financial
    C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024
    GKOS stock results show that Glaukos missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Glaukos Announces First Quarter 2024 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces the Release of its 2023 Sustainability Report
    From Glaukos Corporation
    Via Business Wire
    Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
    From Glaukos Corporation
    Via Business Wire
    Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
    From Glaukos Corporation
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.